Ann: Race Receives Governance Approval for AML EMD & MDS Trial, page-25

Great news; expected outcome; inside the expected timeframe; all systems go.

I hope that this trial helps more people realise what this arm of Race's strategy means. It is a trial to see if there is a treatment for a currently un-curable disease and it is a trial to see if the use of Zantrene stops a huge proportion of cancers that are resistant to immunotherapy treatments.

It is very exciting to be the world first FTO cancer therapy trial in the clinic. I hope people see this fact and that the trial goes well for all concerned.